GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » No.25 Central Pharmaceutical JSC (HSTC:UPH) » Definitions » DeferredTaxAndRevenue

No.25 Central Pharmaceutical JSC (HSTC:UPH) DeferredTaxAndRevenue : ₫0.00 Mil (As of . 20)


View and export this data going back to 2016. Start your Free Trial

What is No.25 Central Pharmaceutical JSC DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

No.25 Central Pharmaceutical JSC's current deferred tax and revenue for the quarter that ended in . 20 was ₫0.00 Mil.

No.25 Central Pharmaceutical JSC DeferredTaxAndRevenue Historical Data

The historical data trend for No.25 Central Pharmaceutical JSC's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

No.25 Central Pharmaceutical JSC DeferredTaxAndRevenue Chart

No.25 Central Pharmaceutical JSC Annual Data
Trend
DeferredTaxAndRevenue

No.25 Central Pharmaceutical JSC Semi-Annual Data
DeferredTaxAndRevenue

No.25 Central Pharmaceutical JSC DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of No.25 Central Pharmaceutical JSC's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.


No.25 Central Pharmaceutical JSC Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
448B Nguyen Tat Thanh, Ward 18, District 4, Ho Chi Minh, VNM
No.25 Central Pharmaceutical JSC is engaged in the manufacturing and trading of pharmaceutical products and cosmetics. Its products comprise Rheumatin, Tribelus, Atorvastatin, and Cezirate among others.

No.25 Central Pharmaceutical JSC Headlines

No Headlines